vs
Montrose Environmental Group, Inc.（MEG）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
Ultragenyx Pharmaceutical Inc.的季度营收约是Montrose Environmental Group, Inc.的1.1倍（$207.3M vs $193.3M），Montrose Environmental Group, Inc.净利率更高（-4.3% vs -62.0%，领先57.8%），Ultragenyx Pharmaceutical Inc.同比增速更快（25.9% vs 2.2%），Montrose Environmental Group, Inc.自由现金流更多（$46.5M vs $-100.8M），过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高（38.0% vs 11.5%）
蒙特罗斯环境集团是一家美国跨国企业，主营各类环境服务，业务覆盖环境行业全产业链，可为公共部门及私营领域客户提供一体化支持。公司总部位于阿肯色州小石城，在美国特拉华州完成注册。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
MEG vs RARE — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $193.3M | $207.3M |
| 净利润 | $-8.2M | $-128.6M |
| 毛利率 | 38.6% | — |
| 营业利润率 | -1.3% | -54.7% |
| 净利率 | -4.3% | -62.0% |
| 营收同比 | 2.2% | 25.9% |
| 净利润同比 | 70.9% | 3.5% |
| 每股收益（稀释后） | $-0.13 | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $193.3M | $207.3M | ||
| Q3 25 | $224.9M | $159.9M | ||
| Q2 25 | $234.5M | $166.5M | ||
| Q1 25 | $177.8M | $139.3M | ||
| Q4 24 | $189.1M | $164.6M | ||
| Q3 24 | $178.7M | $139.5M | ||
| Q2 24 | $173.3M | $147.0M | ||
| Q1 24 | $155.3M | $108.8M |
| Q4 25 | $-8.2M | $-128.6M | ||
| Q3 25 | $8.4M | $-180.4M | ||
| Q2 25 | $18.4M | $-115.0M | ||
| Q1 25 | $-19.4M | $-151.1M | ||
| Q4 24 | $-28.2M | $-133.2M | ||
| Q3 24 | $-10.6M | $-133.5M | ||
| Q2 24 | $-10.2M | $-131.6M | ||
| Q1 24 | $-13.4M | $-170.7M |
| Q4 25 | 38.6% | — | ||
| Q3 25 | 39.4% | — | ||
| Q2 25 | 43.4% | — | ||
| Q1 25 | 39.0% | — | ||
| Q4 24 | 40.8% | — | ||
| Q3 24 | 40.9% | — | ||
| Q2 24 | 39.9% | — | ||
| Q1 24 | 37.8% | — |
| Q4 25 | -1.3% | -54.7% | ||
| Q3 25 | 4.4% | -106.9% | ||
| Q2 25 | 6.4% | -64.8% | ||
| Q1 25 | -5.9% | -102.6% | ||
| Q4 24 | -12.1% | -74.3% | ||
| Q3 24 | -0.6% | -94.6% | ||
| Q2 24 | -1.5% | -79.1% | ||
| Q1 24 | -6.5% | -151.9% |
| Q4 25 | -4.3% | -62.0% | ||
| Q3 25 | 3.7% | -112.8% | ||
| Q2 25 | 7.8% | -69.0% | ||
| Q1 25 | -10.9% | -108.5% | ||
| Q4 24 | -14.9% | -80.9% | ||
| Q3 24 | -5.9% | -95.7% | ||
| Q2 24 | -5.9% | -89.5% | ||
| Q1 24 | -8.6% | -156.8% |
| Q4 25 | $-0.13 | $-1.28 | ||
| Q3 25 | $0.21 | $-1.81 | ||
| Q2 25 | $0.42 | $-1.17 | ||
| Q1 25 | $-0.64 | $-1.57 | ||
| Q4 24 | $-0.91 | $-1.34 | ||
| Q3 24 | $-0.39 | $-1.40 | ||
| Q2 24 | $-0.39 | $-1.52 | ||
| Q1 24 | $-0.53 | $-2.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $11.2M | $421.0M |
| 总债务越低越好 | $277.1M | — |
| 股东权益账面价值 | $451.2M | $-80.0M |
| 总资产 | $981.3M | $1.5B |
| 负债/权益比越低杠杆越低 | 0.61× | — |
8季度趋势，按日历期对齐
| Q4 25 | $11.2M | $421.0M | ||
| Q3 25 | $6.7M | $202.5M | ||
| Q2 25 | $10.5M | $176.3M | ||
| Q1 25 | $30.3M | $127.1M | ||
| Q4 24 | $12.9M | $174.0M | ||
| Q3 24 | $13.0M | $150.6M | ||
| Q2 24 | $16.9M | $480.7M | ||
| Q1 24 | $9.5M | $112.3M |
| Q4 25 | $277.1M | — | ||
| Q3 25 | $302.4M | — | ||
| Q2 25 | $264.6M | — | ||
| Q1 25 | $235.6M | — | ||
| Q4 24 | $204.8M | — | ||
| Q3 24 | $233.0M | — | ||
| Q2 24 | $188.7M | — | ||
| Q1 24 | $280.9M | — |
| Q4 25 | $451.2M | $-80.0M | ||
| Q3 25 | $458.7M | $9.2M | ||
| Q2 25 | $470.3M | $151.3M | ||
| Q1 25 | $444.1M | $144.2M | ||
| Q4 24 | $446.3M | $255.0M | ||
| Q3 24 | $449.2M | $346.8M | ||
| Q2 24 | $448.8M | $432.4M | ||
| Q1 24 | $324.5M | $140.3M |
| Q4 25 | $981.3M | $1.5B | ||
| Q3 25 | $985.7M | $1.2B | ||
| Q2 25 | $998.1M | $1.3B | ||
| Q1 25 | $992.2M | $1.3B | ||
| Q4 24 | $990.4M | $1.5B | ||
| Q3 24 | $1.0B | $1.5B | ||
| Q2 24 | $943.9M | $1.6B | ||
| Q1 24 | $918.1M | $1.3B |
| Q4 25 | 0.61× | — | ||
| Q3 25 | 0.66× | — | ||
| Q2 25 | 0.56× | — | ||
| Q1 25 | 0.53× | — | ||
| Q4 24 | 0.46× | — | ||
| Q3 24 | 0.52× | — | ||
| Q2 24 | 0.42× | — | ||
| Q1 24 | 0.87× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $51.9M | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | $46.5M | $-100.8M |
| 自由现金流率自由现金流/营收 | 24.1% | -48.6% |
| 资本支出强度资本支出/营收 | 2.8% | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $91.2M | $-472.0M |
8季度趋势，按日历期对齐
| Q4 25 | $51.9M | $-99.8M | ||
| Q3 25 | $28.1M | $-91.4M | ||
| Q2 25 | $21.9M | $-108.3M | ||
| Q1 25 | $5.5M | $-166.5M | ||
| Q4 24 | $32.0M | $-79.3M | ||
| Q3 24 | $11.4M | $-67.0M | ||
| Q2 24 | $894.0K | $-77.0M | ||
| Q1 24 | $-22.0M | $-190.7M |
| Q4 25 | $46.5M | $-100.8M | ||
| Q3 25 | $22.3M | $-92.7M | ||
| Q2 25 | $19.9M | $-110.7M | ||
| Q1 25 | $2.4M | $-167.8M | ||
| Q4 24 | $29.7M | $-79.5M | ||
| Q3 24 | $10.2M | $-68.6M | ||
| Q2 24 | $-9.8M | $-79.0M | ||
| Q1 24 | $-29.3M | $-193.9M |
| Q4 25 | 24.1% | -48.6% | ||
| Q3 25 | 9.9% | -58.0% | ||
| Q2 25 | 8.5% | -66.5% | ||
| Q1 25 | 1.3% | -120.5% | ||
| Q4 24 | 15.7% | -48.3% | ||
| Q3 24 | 5.7% | -49.2% | ||
| Q2 24 | -5.6% | -53.7% | ||
| Q1 24 | -18.9% | -178.2% |
| Q4 25 | 2.8% | 0.5% | ||
| Q3 25 | 2.6% | 0.8% | ||
| Q2 25 | 0.8% | 1.5% | ||
| Q1 25 | 1.8% | 1.0% | ||
| Q4 24 | 1.2% | 0.1% | ||
| Q3 24 | 0.6% | 1.2% | ||
| Q2 24 | 6.1% | 1.4% | ||
| Q1 24 | 4.7% | 3.0% |
| Q4 25 | — | — | ||
| Q3 25 | 3.36× | — | ||
| Q2 25 | 1.19× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MEG
暂无分部数据
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
